1. Efficacy and safety of nusinersen in infants with presymptomatic spinal muscular atrophy (SMA): Interim results from the NURTURE study. (June 2017) Authors: Bertini, E.; Hwu, W.-L.; Reyna, S.P.; Farwell, W.; Gheuens, S.; Sun, P.; Zhong, Z.J.; De Vivo, D.C. Journal: European journal of paediatric neurology Issue: Volume 21(2017)Supplement 1 Page Start: e14 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Efficacy and safety of nusinersen in infants with spinal muscular atrophy (SMA): Final results from the phase 3 ENDEAR study. (June 2017) Authors: Finkel, R.; Kuntz, N.; Mercuri, E.; Chiriboga, C.A.; Darras, B.; Topaloglu, H.; Montes, J.; Su, J.; Zhong, Z.J.; Gheuens, S.; Bennett, C.F.; Schneider, E.; Farwell, W. Journal: European journal of paediatric neurology Issue: Volume 21(2017)Supplement 1 Page Start: e14 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. FV3-like ranavirus infection outbreak in black-spotted pond frogs (Rana nigromaculata) in China. (October 2018) Authors: Mu, W.H.; Geng, Y.; Yu, Z.H.; Wang, K.Y.; Huang, X.L.; Ou, Y.P.; Chen, D.F.; He, C.L.; Zhong, Z.J.; Yang, Z.X.; Lai, W.M. Journal: Microbial pathogenesis Issue: Volume 123(2018) Page Start: 111 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. SAT0188 Early clinical improvement in SLE patients treated with belimumab. (23rd January 2014) Authors: Doria, A.; Sanchez-Guerrero, J.; Tegzová, D.; Ginzler, E.M.; Zhong, Z.J.; Dennis, G.; Wallace, D.J. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 535 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. SAT0192 Post-hoc analysis to assess effect of belimumab in patients on mycophenolate mofetil with renal manifestations at baseline. (23rd January 2014) Authors: Houssiau, F.; Dooley, M.A.; Aranow, C.; D'Cruz, D.; Askanase, A.; Roth, D.A.; Cooper, S.; Zhong, Z.J.; Freimuth, W.; Ginzler, E.M. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 536 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. SAT0195 Impact of mycophenolate mofetil and/or corticosteroid treatment on outcomes of belimumab treatment in SLE. (23rd January 2014) Authors: Schneider, M.; Buyon, J.; Dooley, M.A.; Ginzler, E.M.; Cooper, S.; Zhong, Z.J.; Keenan, G.F.; Merrill, J.T. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 537 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. SAT0197 Baseline laboratory characteristics from the combined placebo groups in the bliss trials are predictive of severe flare at 24 weeks. (23rd January 2014) Authors: Petri, M.; van Vollenhoven, R.F.; Levy, R.A.; Navarra, S.; Cervera, R.; Zhong, Z.J.; Freimuth, W.; Buyon, J. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 538 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. SAT0204 Predictors for SLE flares: Baseline disease activity and demographic characteristics from the bliss trials' combined placebo groups. (23rd January 2014) Authors: van Vollenhoven, R.F.; Petri, M.; Levy, R.A.; Navarra, S.; Buyon, J.; Zhong, Z.J.; Freimuth, W.; Cervera, R. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 540 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗